The potential risks and benefits of cladribine should therefore be carefully considered before treatment is commenced in any patient with renal impairment crcl. In some cases, health care professionals may use the trade name leustatin tm or other names 2cda or 2chlorodeoxyadenosine when referring to the generic drug name cladribine. This emedtv web page lists other precautions and warnings for cladribine, including details on serious complications that may occur with the drug. Since the growth of normal body cells may also be affected by cladribine. Cladribine intravenous route description and brand names. The following data is based on the product molecular weight 285. It is an antineoplastic agent anticancer drug that is formulated for oral administration. Cladribine is used to treat hairy cell leukemia a type of blood cancer. Consumer information about the medication cladribine injection leustatin, includes side effects, drug interactions, recommended dosages, and storage information. Highlights of prescribing information these highlights do not include all the information needed to use pomalyst safely and effectively. Theyll give your presentations a professional, memorable appearance the kind of sophisticated look that todays audiences expect. It is used to treat hairy cell leukemia, a cancer of the blood and bone marrow. Leustatin cladribine injection for intravenous infusion.
Mavenclad cladribine tablets prescribing information hcp. Due to inconsistencies between the drug labels on dailymed and the pill images provided by rximage, we no longer display the rximage pill images associated with drug labels we anticipate reposting the images once we are able identify and filter out images that do not match the information. Patients who had received interferon beta or glatiramer acetate during the gap period had to discontinue their diseasemodifying drug dmd. See what others have said about cladribine, including the effectiveness, ease of use and side effects. It is also sometimes used to treat other kinds of cancer, as determined by your doctor. The most common side effect is a drop in the number of your white blood cells that fight infections lymphopenia. Cladribine is also being studied in the treatment of other types of cancer. Other effects may not be serious but may cause concern. What is a patient information leaflet and why is it useful. Cladribine is the generic name for the trade name drug leustatin tm. Definition from the nci drug dictionary detailed scientific definition and other names for this drug.
Disclosures acknowledgements pi of trials sponsored by novartis, roche, teva, medday. This means youve had two or more disabling relapses in the past year and mri scans show you have more, or bigger, lesions. Cladribine fda prescribing information, side effects and uses. Jan 17, 2020 mavenclad 10 mg tablets patient information leaflet pil by merck. Cladribine 2chlorodeoxyadenosine 2cda is a synthetic deoxyadenosine analog that results in preferential and sustained reduction of lymphocyte t and b subtypes. Cladribine injection leustatin side effects, medical. Cladribine interferes with the growth of cancer cells, which are eventually destroyed. In the clinical study data base of cladribine in ms 1,976patients, 8,650patient years no case of pml has been reported.
The patient information leaflet pil is the leaflet included in the pack with a medicine. You take mavenclad as a pill in two treatment courses, twelve months apart to reduce the number and severity of relapses. In general, the apparent volume of distribution of cladribine is approximately 9 lkg, indicating an extensive distribution in body tissues. Leustatin cladribine injection for intravenous infusion only. Mavenclad 10 mg tablets patient information leaflet pil. Oct 11, 2010 here more on cladribine from the financial times, wall street journal and bloomberg. Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020. Oral cladribine is contraindicated in females and males of reproductive potential who do not plan to use effective contraception during treatment and for 6 months after the last dose in each treatment course. See the respective package inserts for complete vzig and ig prescribing information.
Safety of cladribine tablets in the treatment of patients with multiple. We report the results of a 96week phase 3 trial of a shortcourse oral tablet therapy in patient. A pharmacy bulk package is a container of a sterile preparation for parenteral use that contains many single doses. Click the image and it will be inserted into the slide. Each ml of cladribine injection, usp contains 1 mg of the active ingredient and 9 mg 0. In the eu summary of product characteristics smpc, criteria for. Cladribine doesnt weaken your immune system as much as some other ms drugs. In hairy cell leukaemia, a 7day infusion can induce a response rate in over 60% of patients. Oct 01, 2019 cladribine injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. This causes breaks in dna strands and leads to cell death. Worlds best powerpoint templates crystalgraphics offers more powerpoint templates than anyone else in the world, with over 4 million to choose from. Book traversal links for cladribine fdas top blockbuster. Jan 01, 2017 cladribine belongs to the group of medicines called antimetabolites. Leustatin cladribine injection for intravenous infusion only warning.
Background cladribine provides immunomodulation through selective targeting of lymphocyte subtypes. Side effects can include a reduced white blood cell count. This approval for cladribine tablets means that people with multiple sclerosis in russia will benefit soon from this effective oral treatment, said elmar schnee, member of the board of merck kgaa and head of the merck serono division. Due to inconsistencies between the drug labels on dailymed and the pill images provided by rximage, we no longer display the rximage pill images associated with drug labels. A new drug application was rejected by european regulators in 2010 and by the us food and drug administration in 2011.
Advice from a cardiologist should be sought to determine the most appropriate monitoring strategy which may include overnight monitoring during treatment initiation, if treatment with mayzent is considered in patients. Cytarabine injection, an antineoplastic, is a sterile solution of cytarabine for intravenous and subcutaneous use which contains no preservative and is available in 20 mgml mg50 ml pharmacy bulk package. Cladribine is relatively specific for lymphocytes on account of their high ratio of deoxycytidine kinase to deoxynucleotidase. The mean time on study including followup was approximately 4. Four 20% were treated with iv cladribine, and 16 80% were treated with subcutaneous sc cladribine. Cladribine tablets for treating relapsingremitting. Merck kgaas cladribine tablets for ms approved in russia. May 18, 2018 if cladribine is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. It has not been approved for use in the united states or canada. The benefitrisk balance of cladribine in patients with rrms and specifically patients with. Cladribine was originally administered intravenously as a continuous infusion at a dose of 0. Cladribine injection leustatin side effects, medical uses. There was no increase in malignancy rates for cladribine in patients with.
Cladribine injection, usp is available in singleuse vials containing 10 mg 1 mgml of cladribine, a chlorinated purine nucleoside analog. Effect of cladribine tablets on lymphocyte reduction and repopulation. Cladribine tablets for treating relapsingremitting multiple. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Mavenclad is contraindicated in patients with current malignancy. Medlineplus information on cladribine a lay language summary of important information about this drug that may include the following. Nov 09, 2018 cladribine is a cancer medication that interferes with the growth and spread of cancer cells in the body. Cladribine fdas top blockbuster decisions fiercebiotech. Cladribine gets european approval in ms medpage today. A placebocontrolled trial of oral cladribine for relapsing. Study 2 addon study enrolled patients who had experienced one or more. Norvir ritonavir tablets, for oral use warnings and precautions norvir ritonavir oral solution the following have been observed in patients receiving norvir.
Cladribine is teratogenic in mice and rabbits and consequently has the potential to cause fetal harm when administered to a pregnant woman. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions. This is usually reversible and appears to be dose dependent. The other group received treatment in the reversed order and the relapse rate was 0. Moderate t cell effect, yet high efficacy t baker d, et al. Highlights of prescribing information macular edema. Leustatin injection is available in singleuse vials containing 10 mg 1 mgml of cladribine, a chlorinated purine nucleoside analog. The study was carried out on 20 egyptian hairy cell leukemia cases. Jul, 2010 cladribine tablets will be available in russia under the trade name movectro. Cladribine side effects, dosage, interactions drugs.
Mavenclad is a disease modifying drug for very active relapsing remitting ms. Speaker disclosures the presenter has no real or perceived conflicts of interest related to this presentation. In the clinically significant adverse reactions subsection of the adverse reactions section, the following language should be added revised language is underlined. Cladribine is a purine analogue which passively enters cells and is phosphorylated by deoxycytidine kinase. Cladribine is an anticancer antineoplastic or cytotoxic chemotherapy drug. The drug is most active in cells with high levels of deoxycytidine kinase, such as lymphocytes 38, 39.
Because of its safety profile, use of mavenclad is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of ms. Suppression of bone marrow function should be anticipated. If chickenpox develops, treatment with antiviral agents should be considered. Mavenclad 10 mg tablets patient information leaflet pil by merck. Ppt participant and local issues powerpoint presentation. It is a clear, colorless, sterile, preservativefree, isotonic solution. So the risk of getting infections isnt as high as with some dmts. Cladribine is a cancer medication that interferes with the growth and spread of cancer cells in the body. In the clinical trial program of cladribine in ms, 1,976 patients received cladribine for a total of 9,509 patient years. Cladribine has been shown to be embryotoxic in mice when given at doses equivalent to the recommended dose. A new drug application was rejected by european regulators in 2010 and by the us food and drug administration in. Read more about the prescription drug cladribine injection. Cladribine fda prescribing information, side effects and. Angiomax is intended for use with aspirin 300325 mg daily and has been studied only in patients receiving concomitant aspirin.
Here more on cladribine from the financial times, wall street journal and bloomberg. Since the growth of normal body cells may also be affected by cladribine, other effects will also occur. Safety and efficacy of cladribine tablets in patients with relapsing. Open your powerpoint presentation on the page you want to insert the pdf within. Leustatin cladribine injection should be administered under the supervision of a. After administration, cladribine enters various cells and once inside the cell, the enzyme deoxycytidine kinase catalyzes the attachment of three phosphate groups. Cladribine is approved to be used in 24hour continuous infusion for the treatment of lowgrade lymphoma by the ministry of health, labor and welfare in japan. Cladribine is a small molecule that may interfere with the behavior and the proliferation of certain white blood cells, particularly lymphocytes, which are thought to be involved in the pathological process of ms. These regimens are all very effective but often show relevant toxicity. In august 2017, cladribine was approved for the treatment of people with highly active relapsing forms of ms in the european union, norway, liechtenstein, and iceland. See full prescribing information for complete boxed warning. This program may contain the mention of suppliers, brands, pro. Some of these may be serious and must be reported to your doctor. Neurology multiple sclerosis cladribine gets european approval in ms more potent ms drugs approved since initial rejection.
Dec 14, 2009 why is dailymed no longer displaying pill images on the search results and drug info pages. Pdf cladribine treatment in twohour intravenous infusion. Why is dailymed no longer displaying pill images on the search results and drug info pages. Cladribine triphosphate, in turn, inhibits dna synthesis, inhibits dna repair, and results in apoptosis death of the cell. Leustatin cladribine injection for intravenous infusion only warning leustatin cladribine injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. However, a baseline magnetic resonance imaging mri should be performed before initiating mavenclad usuallywithin 3months. Cladribine 2chlorodeoxyadenosine 2cda is a synthetic deoxyadenosine analog that results in preferential and sustained reduction of lymphocyte t. Winner of the standing ovation award for best powerpoint templates from presentations magazine. This guidance has been updated and replaced by cladribine for treating relapsingremitting multiple sclerosis. Cladribine is used to treat multiple sclerosis and a type of leukemia hairy cell leukemia 40.
Malignancies mavenclad may increase the risk of malignancy. Cladribine belongs to the group of medicines called antimetabolites. Previously untreated patients have a higher response rate. Merck serono has applied for marketing approval of cladribine tablets in the european union, the united states and other locations.
For a complete listing, see the dosage forms, composition. Cladribine april 19, 2018 nonproprietary name cladribine safety measure precautions should be revised in the package insert. The recommended dose of angiomax is an intravenous iv bolus dose of. Cladribine api manufacturers suppliers drug master. If cladribine is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. I have put teriflunomide and daclizumab in orange because they are not labeled as being. Leustatin cladribine injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Benefitrisk assessment of cladribine using multicriteria decision. Cladribine cladribine dose, indications, adverse effects.
Cladribine is teratogenic in mice and rabbits and consequently has the potential to cause fetal. Before receiving cladribine, your doctor will need to know if you have an infection or any allergies. Weiterer et al 2015 galactomannan and zymosan block the epinephrineinduced particle transport in tracheal epithelium. Aug 25, 2017 neurology multiple sclerosis cladribine gets european approval in ms more potent ms drugs approved since initial rejection. Mavenclad cladribine tablets is indicated for the treatment of relapsing forms of multiple sclerosis ms, to include relapsingremitting disease and active secondary progressive disease, in adults. It reduces the number of relapses by about half 50%, compared to taking placebo.
Subsequently cladribine has been administered intravenously, as a 2 h infusion for 5 consecutive days or weekly for 7 weeks, or subcutaneously. Serious neurological toxicity including irreversible paraparesis and quadraparesis. The pdf file should be the first option within the insert dialog window. Comparative study between intravenous and subcutaneous. Cladribine plasma concentration after intravenous administration declines multiexponentially with an average halflife of 6. Dadenosine is a synthetic antineoplastic agent for continuous intravenous infusion. Highlights of prescribing information these highlights do not include all the information needed to use norvir safely and effectively. Do you know of a great paper that uses cladribine from tocris. Find patient medical information for cladribine intravenous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Neurologicreports of severe medical events have been associated with the intrathecal.
Cladribine is a cytotoxic agent with high activity in hematological malignancies. Leustatin cladribine injection also commonly known as 2chloro2deoxy. Sep 12, 2019 provides accurate and independent information on more than 24,000 prescription drugs, overthecounter medicines and natural products. There are no adequate and well controlled studies in pregnant women.
218 294 614 1471 89 468 730 934 22 1375 448 186 535 989 822 965 304 245 143 545 402 729 1017 722 1421 518 899 706 1043 720 1126 904 887 1063 374 883 259 519 1111 710 308 695 478 1428 180 1076 986 849